Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-18T16:13:27.874Z Has data issue: false hasContentIssue false
  • English
  • Français

Síntomas extrapiramidales graves con fluvoxamina a pesar de la supresión de neurolépticos

Published online by Cambridge University Press:  12 May 2020

P. Thomas ,
J. Roche ,
M. Maron ,
O. Cotencin ,
G. Vaiva  and
M. Goudemand
P. Thomas
Affiliation:
Departamento de Psiquiatría, Universidad de Lille II, Escuela de Medicina, Francia
J. Roche
Affiliation:
Departamento de Psiquiatría, Universidad de Lille II, Escuela de Medicina, Francia
M. Maron
Affiliation:
Departamento de Psiquiatría, Universidad de Lille II, Escuela de Medicina, Francia
O. Cotencin
Affiliation:
Departamento de Psiquiatría, Universidad de Lille II, Escuela de Medicina, Francia
G. Vaiva
Affiliation:
Departamento de Psiquiatría, Universidad de Lille II, Escuela de Medicina, Francia
M. Goudemand
Affiliation:
Departamento de Psiquiatría, Universidad de Lille II, Escuela de Medicina, Francia

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Carta al director
Information
European Psychiatry (Ed. Española) , Volume 4 , Issue 2 , March 1997 , pp. 129 - 130
Copyright
Copyright © European Psychiatric Association 1997

References

Bibliografia

Arya, DExtrapyramidal symptoms with selective serotonin reuptake inhibitors. Br J Psychiatry 1994; 165: 728–33.CrossRefGoogle ScholarPubMed
Coulter, DPillans, PFluoxetine and extrapyramidal side effects. Am J Psychiatry 1995; 152: 122–5.Google ScholarPubMed
Crewe, HLennard, MTucker, GWoods, FHaddock, RThe effects of selective serotonine reuptake inhibitors on cytochrome P4502D6 activity in human liver microsomes. Br J Clin Pharmacol 1992; 34: 262–5.CrossRefGoogle Scholar
Wils, VExtrapyramidal symptoms in a patient treated with fluvoxamine. J Neurol Neurosurg Psychiatry 1992; 55: 330–1.CrossRefGoogle Scholar